the Company holds its shares at 99.99 percent, the purchase, and acquisition, as mentioned above, are not subject to the acquisition or disposal of assets transaction or connected transaction pursuant

for 2Q/2018 Bangchak Corporation Plc. I 2 Table of Content Management Discussion & Analysis of Business Operation 03 Executive Summary 06 Statement of Income 08 Business Performance 08 Refinery

offering of the newly issued preferred shares to be issued and offered to the existing shareholders in proportion to their shareholdings and to specific investors, disposal of assets, and convening of the

the rights to purchase the Company’s ordinary shares under the warrants to purchase the Company’s ordinary shares No. 4 (U-W4) Agenda 12 To consider and approve the disposal of certain assets of the

the operation of the assets under (1) (2) (3) or (4) not less than seventy-five percent of the company’s total income in each fiscal year and; (b) meets one of the following criteria; 1. has or will

of America 3.2 Summary of financial information Unit : USD million 2016 Assets 45.3 Liabilities 2.9 Shareholders’ equity 42.4 Income 1.2 Total expenses (30.1) Net profit (loss) (28.9) 3.3 Shareholding

financial status as of December 31, 2017 are summarized as below: • Assets As of December 31, 2017, the Company and its subsidiaries have a total asset by 704 MB which decreased from year 2017 by 331 MB and

income Revenue from hospital operations The Company booked revenue from hospital operations amounting to Baht 409.80 million and Baht 413.02 million for the year ended 31 December 2016 and the year ended

and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for

29.1 Finance costs 250.93 403.07 (152.14) (37.7) Income tax expense 215.17 164.03 51.14 31.2 Total expenses 2,211.89 2,102.74 109.15 5.2 2,175.99 2,309.70 (133.71) (5.8) Non-controlling Interests - (3.04